LNA Santé (LNA) Q3 2024 TU earnings summary

Executive summary

• Operating revenue for the first nine months of 2024 reached €582.2m, reflecting dynamic activity across all business lines and a high occupancy rate in nursing homes at 94.2%.

• Adjusted organic growth was 5.8% year-over-year, with reported growth at 9.1%.

• Strong development in home-based and outpatient activities, with significant increases in patient numbers for hospitalisation at home and day hospitalisation.

• Active preparation for property disposals, with over €50m in potential sales from 272 units brought to market in 2024.

Financial highlights

• Q3 2024 operating sales were €195.9m, up 10.9% year-over-year; nine-month operating sales totaled €582.2m, up 9.1% reported and 5.8% adjusted organic.

• Healthcare sector France sales reached €323.3m, up 11.3% reported and 5.3% adjusted organic; nursing home revenue in France was €224.9m, up 6.3% organically.

• International sector sales were €28.9m, up 5.4% organically.

• Property sales to end September 2024 totaled €6.4m.

Outlook and guidance

• Adjusted organic growth target for 2024 is confirmed at +5%.

• The company expects continued strengthening of property sales in the coming months and is prepared for regulatory changes impacting healthcare reimbursement.